136 related articles for article (PubMed ID: 20153988)
1. Identification and characterization of oxidation and deamidation sites in monoclonal rat/mouse hybrid antibodies.
Timm V; Gruber P; Wasiliu M; Lindhofer H; Chelius D
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):777-84. PubMed ID: 20153988
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies.
Chelius D; Rehder DS; Bondarenko PV
Anal Chem; 2005 Sep; 77(18):6004-11. PubMed ID: 16159134
[TBL] [Abstract][Full Text] [Related]
3. Characterization and comparability of stress-induced oxidation and deamidation on vulnerable sites of etanercept products.
Huang LJ; Chiang CW; Lee YW; Wang TF; Fong CC; Chen SH
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():189-197. PubMed ID: 27237733
[TBL] [Abstract][Full Text] [Related]
4. Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
Terashima I; Koga A; Nagai H
Anal Biochem; 2007 Sep; 368(1):49-60. PubMed ID: 17617368
[TBL] [Abstract][Full Text] [Related]
5. A conventional procedure to reduce Asn deamidation artifacts during trypsin peptide mapping.
Kori Y; Patel R; Neill A; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():107-13. PubMed ID: 26720699
[TBL] [Abstract][Full Text] [Related]
6. Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody.
Chumsae C; Gaza-Bulseco G; Sun J; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):285-94. PubMed ID: 17182291
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the deamidation rates of major deamidation sites in a Fab fragment of mouse IgG1-κ by capillary isoelectric focusing of mutated Fab fragments.
Shimura K; Hoshino M; Kamiya K; Enomoto M; Hisada S; Matsumoto H; Novotny M; Kasai K
Anal Chem; 2013 Feb; 85(3):1705-10. PubMed ID: 23278172
[TBL] [Abstract][Full Text] [Related]
8. Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping.
Zhang YT; Hu J; Pace AL; Wong R; Wang YJ; Kao YH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():65-71. PubMed ID: 24999246
[TBL] [Abstract][Full Text] [Related]
9. Method to differentiate asn deamidation that occurred prior to and during sample preparation of a monoclonal antibody.
Gaza-Bulseco G; Li B; Bulseco A; Liu HC
Anal Chem; 2008 Dec; 80(24):9491-8. PubMed ID: 19072263
[TBL] [Abstract][Full Text] [Related]
10. Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal Antibodies.
Yan Q; Huang M; Lewis MJ; Hu P
MAbs; 2018; 10(6):901-912. PubMed ID: 29958069
[TBL] [Abstract][Full Text] [Related]
11. Unique Impacts of Methionine Oxidation, Tryptophan Oxidation, and Asparagine Deamidation on Antibody Stability and Aggregation.
Alam ME; Slaney TR; Wu L; Das TK; Kar S; Barnett GV; Leone A; Tessier PM
J Pharm Sci; 2020 Jan; 109(1):656-669. PubMed ID: 31678251
[TBL] [Abstract][Full Text] [Related]
12. Microheterogeneity of mouse antidextran monoclonal antibodies.
Mimura Y; Kabat EA; Tanaka T; Fujimoto M; Takeo K; Nakamura K
Electrophoresis; 1995 Jan; 16(1):116-23. PubMed ID: 7537656
[TBL] [Abstract][Full Text] [Related]
13. Identification of sites of degradation in a therapeutic monoclonal antibody by peptide mapping.
Kroon DJ; Baldwin-Ferro A; Lalan P
Pharm Res; 1992 Nov; 9(11):1386-93. PubMed ID: 1475223
[TBL] [Abstract][Full Text] [Related]
14. 2D NMR Analysis of the Effect of Asparagine Deamidation Versus Methionine Oxidation on the Structure, Stability, Aggregation, and Function of a Therapeutic Protein.
Bandi S; Singh SM; Shah DD; Upadhyay V; Mallela KMG
Mol Pharm; 2019 Nov; 16(11):4621-4635. PubMed ID: 31483994
[TBL] [Abstract][Full Text] [Related]
15. Determination of deamidation artifacts introduced by sample preparation using 18O-labeling and tandem mass spectrometry analysis.
Du Y; Wang F; May K; Xu W; Liu H
Anal Chem; 2012 Aug; 84(15):6355-60. PubMed ID: 22881398
[TBL] [Abstract][Full Text] [Related]
16. Selective deamidation of recombinant human stem cell factor during in vitro aging: isolation and characterization of the aspartyl and isoaspartyl homodimers and heterodimers.
Hsu YR; Chang WC; Mendiaz EA; Hara S; Chow DT; Mann MB; Langley KE; Lu HS
Biochemistry; 1998 Feb; 37(8):2251-62. PubMed ID: 9485371
[TBL] [Abstract][Full Text] [Related]
17. Asparagine deamidation dependence on buffer type, pH, and temperature.
Pace AL; Wong RL; Zhang YT; Kao YH; Wang YJ
J Pharm Sci; 2013 Jun; 102(6):1712-1723. PubMed ID: 23568760
[TBL] [Abstract][Full Text] [Related]
18. Glutamine deamidation of a recombinant monoclonal antibody.
Liu H; Gaza-Bulseco G; Chumsae C
Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4081-8. PubMed ID: 19021137
[TBL] [Abstract][Full Text] [Related]
19. Rate of Asparagine Deamidation in a Monoclonal Antibody Correlating with Hydrogen Exchange Rate at Adjacent Downstream Residues.
Phillips JJ; Buchanan A; Andrews J; Chodorge M; Sridharan S; Mitchell L; Burmeister N; Kippen AD; Vaughan TJ; Higazi DR; Lowe D
Anal Chem; 2017 Feb; 89(4):2361-2368. PubMed ID: 28194941
[TBL] [Abstract][Full Text] [Related]
20. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
